We are live on
!
Find out more
RC
Renaissance Capital Portfolio holdings
AUM
$138M
1-Year Est. Return
39.59%
This Fund
S&P 500
This Quarter
Est. Return
+16.17%
1 Year Est. Return
+39.59%
3 Year Est. Return
+247.63%
5 Year Est. Return
+187.28%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$40.8M
(+30%)
Cap. Flow
+$23.1M
Cap. Flow
% of AUM
13.13%
Top 10 Holdings %
Top 10 Hldgs %
54.18%
Holding
90
New
2
Increased
69
Reduced
3
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Airbnb
ABNB
|
+$5.05M |
| 2 |
Roblox
RBLX
|
+$2.42M |
| 3 |
DoorDash
DASH
|
+$2.38M |
| 4 |
Kenvue
KVUE
|
+$2.05M |
| 5 |
Albertsons Companies
ACI
|
+$1.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$4.46M |
| 2 |
GTM
ZoomInfo Technologies
GTM
|
+$2.26M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
+$1.5M |
| 4 |
Shift4
FOUR
|
+$1.27M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$1.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.53% |
| 2 | Consumer Discretionary | 31.82% |
| 3 | Financials | 12% |
| 4 | Communication Services | 8.81% |
| 5 | Consumer Staples | 3.22% |
Similar funds
LDNAM
PF
DW
FP
SIP
TC
PBRA
LPAM
Renaissance Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Capital held 90 positions worth $176M, up 30% from $135M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Renaissance Capital deployed $23.1M of net new capital in Q2 2023, opening 2 new positions and adding to 69 existing holdings. Its largest new stake was Kenvue: 78,513 shares worth $2.07M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was XPeng, an estimated $892K trimmed.
- Renaissance Capital's largest Q2 2023 buy was Kenvue: 78,513 shares worth $2.07M.
- Renaissance Capital added most to Airbnb in Q2 2023, an estimated $5.05M increase.
- Renaissance Capital's biggest Q2 2023 reduction was XPeng, cutting an estimated $892K.
- Renaissance Capital fully exited Royalty Pharma in Q2 2023, selling an estimated $4.46M.
- Renaissance Capital's ten largest holdings make up 54% of its $176M portfolio in Q2 2023.
- Renaissance Capital opened 2 new positions and closed 15 in Q2 2023.
- Renaissance Capital's portfolio value rose 30% quarter-over-quarter to $176M.
Based on Renaissance Capital's 13F filing for Q2 2023, filed 17 Jul 2023.